共 50 条
- [1] PROSTACYCLIN (PGI2) INHIBITS THE DEVELOPMENT IN HUMAN-PLATELETS OF ADP AND ARACHIDONIC ACID-INDUCED SHAPE CHANGE AND PROCOAGULANT ACTIVITY PROSTAGLANDINS, 1980, 20 (06): : 1103 - 1116
- [2] EFFECT OF PURIFIED HUMAN THROMBIN ON PROSTACYCLIN (PGI2)-TREATED PLATELETS CLINICAL RESEARCH, 1978, 26 (03): : A357 - A357
- [5] PROSTACYCLIN (PGI2) INHIBITS THE DEVELOPMENT IN PLATELETS OF ADP AND ARACHIDONATE-MEDIATED SHAPE CHANGE AND PROCOAGULANT ACTIVITY CLINICAL RESEARCH, 1979, 27 (02): : A293 - A293
- [6] EFFECT OF PROSTACYCLIN (PGI2) ON PLATELETS AND FIBRINOLYTIC-ACTIVITY IN PATIENTS WITH ARTERIOSCLEROSIS OBLITERANS PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1982, 14 (06): : 485 - 498
- [7] HUMAN-PLATELETS HAVE SEPARATE RECEPTORS FOR PROSTACYCLIN (PGI2) AND PROSTAGLANDIN-E2 (PGE2) CLINICAL RESEARCH, 1984, 32 (01): : A78 - A78
- [8] GENERATION OF AN ACTIVE STABLE METABOLITE OF PROSTACYCLIN (PGI2) BY 9-HYDROXY-PROSTAGLANDIN DEHYDROGENASE OF HUMAN-PLATELETS CLINICAL RESEARCH, 1980, 28 (02): : A500 - A500
- [9] STUDIES ON THE MECHANISM OF HEPARIN NEUTRALIZATION OF PLATELETS ANTIAGGREGATORY ACTIVITY OF PROSTACYCLIN (PGI2) CLINICAL RESEARCH, 1983, 31 (02): : A322 - A322